Establishment and Validation of Early-warning Model of Perioperative Pain for the Elders

January 13, 2020 updated by: Yi Feng, MD, Peking University People's Hospital

Study on Comprehensive Strategy of Perioperative Pain Prevention and Treatment in Elderly Patients -- Establishment and Validation of Early-warning Model of Perioperative Pain for the Elders

This study will collect perioperative pain-related data of elderly patients in multi-centers. Analyzing these collected data to find the high-risk factors of postoperative pain in elderly patients and to establish an early-warning model of perioperative pain in elderly patients, so as to improve the ability of assessing the risks of postoperative pain in elderly patients and providing an early warning.

Study Overview

Status

Unknown

Detailed Description

This study will collect perioperative pain-related data of elderly patients in multi-centers, including: preoperative general data, intraoperative anesthesia and surgical data, clinical laboratory data, postoperative pain and intervention, postoperative complications and quality of life. Analyzing these collected data to find the high-risk factors of postoperative pain in elderly patients and to establish an early-warning model of perioperative pain in elderly patients, so as to improve the ability of assessing the risks of postoperative pain in elderly patients and providing an early warning.

Study Type

Observational

Enrollment (Anticipated)

6000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100044
        • Recruiting
        • Peking University People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients aged 18 years or older undergoing general or regional anesthesia of any procedures, mainly include: breast surgery, thoracic surgery, abdominal surgery, total knee or hip replacement surgery and spine surgery.

Description

Inclusion Criteria:

  • 18 years or older
  • Undergoing general or regional anesthesia
  • Hospitalized for at least 24 hours after surgery
  • Able to give informed consent
  • Able to read and write

Exclusion Criteria:

  • Existing diagnoses of psychiatric or neurologic pathology
  • A history of substance abuse
  • Admitted to ICU after surgery
  • Patients with advanced tumors who have received preoperative chemotherapy or who are expected to receive postoperative chemotherapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
The elders
Patients aged over 59 years old
The young adults
Patients aged from 18 to 59 years old

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain trajectories after surgery
Time Frame: within 6 months
The pain trajectory is the vector of mean pain severity domain score (from 0 to 10) measured with pain severity domain of the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R)
within 6 months
Pain trajectories after surgery
Time Frame: within 6 months
The pain trajectory is the vector of mean pain severity domain score (from 0 to 10) measured with Brief Pain Inventory -Short Form (BPI-SF) within 6 months
within 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcome of 6-mins-walking test
Time Frame: 1, 3, 7, 14, 21, 30, 60, 90, 120, 150 and180 days postoperation
Walking distance of 6 minutes
1, 3, 7, 14, 21, 30, 60, 90, 120, 150 and180 days postoperation
Postoperative duration of stay in hospital
Time Frame: 30 days postoperation
The duration when patients stay in hospital after surgery.
30 days postoperation
Number of readmission within 30 days after surgery
Time Frame: Up to 30 days postoperation
Readmission indicates unplanned readmission after hospital discharge.
Up to 30 days postoperation
Complications within 30 days after surgery
Time Frame: Up to 30 days postoperation
Complications within 30 days after surgery will be classified using Clavien-Dindo Classification of Surgical Complications, ranging from Grade I(Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions) to Grade V(death of a patient).
Up to 30 days postoperation
The trajectories of health related quality of life(HRQoL)
Time Frame: 1, 3, 7, 14, 21, 30, 60, 90, 120, 150 and180 days postoperation
The trajectory of HRQoL is the vector of Utility values measured with EuroQol five-dimensional questionnaire(EQ-5D)taken over 6 months(days 1, 3, 7,14, 21, 30, 60, 90, 120, 150,180; Day 0 is the day of surgery). The EQ-5D measures health on five domains (mobility, self-care, usual activities, pain discomfort, and anxiety-depression), and the scores will be combined using Chinese general population weights to generate a single utility or index score. Utility values for the EQ-5D range from 1.00 to -0.391, where a score of 0 and 1 are regarded as equivalent to death and 'perfect health', respectively, and a score < 0 is considered as health state that is 'worse than death'.
1, 3, 7, 14, 21, 30, 60, 90, 120, 150 and180 days postoperation
Ambulation time
Time Frame: Up to 30 days postoperation
The first time when patients can get off of bed and walk after surgery
Up to 30 days postoperation
Oral feeding time
Time Frame: Up to 30 days postoperation
The first time when patients begin oral feeding after surgery
Up to 30 days postoperation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Feng Yi, MD, PhD, Peking University People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 13, 2019

Primary Completion (Anticipated)

December 12, 2020

Study Completion (Anticipated)

December 12, 2020

Study Registration Dates

First Submitted

January 12, 2020

First Submitted That Met QC Criteria

January 13, 2020

First Posted (Actual)

January 14, 2020

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 13, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2019PHB258-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

3
Subscribe